BIOAF
biOasis Technologies Inc

45
Mkt Cap
$397,070.00
Volume
1,000.00
52W High
$0.0006
52W Low
$0.00
Price
$0.0002
BIOAF Fundamentals
Prev Close
$0.0006
Open
$0.0002
50D MA
$0.0002
Beta
48.13
Avg. Volume
157.14
Loading...
Loading...
biOasis Technologies, Inc. operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier. The company was founded by Robin B. Hutchison on November 3, 2006 and is headquartered in New Haven, CT.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Bioasis Technologies Inc?
What is the 52-week high for Bioasis Technologies Inc?
What is the 52-week low for Bioasis Technologies Inc?
What is Bioasis Technologies Inc stock price today?
What was Bioasis Technologies Inc stock price yesterday?
What is the 50-day moving average of Bioasis Technologies Inc?

Latest BIOAF News

View
No BIOAF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.